Next Article in Journal
Real-World Adjuvant TAC or FEC-D for HER2-Negative Node-Positive Breast Cancer in Women Less Than 50 Years of Age
Previous Article in Journal
Palliative Chemotherapy in Advanced Colorectal Cancer Patients 80 Years of Age and Older
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Provincial Elections and Timing of Cancer Drug Funding

1
Division of Medical Oncology, BC Cancer Agency, Vancouver Centre, Vancouver, BC, Canada
2
Department of Medicine, Queen’s University, Kingston, ON, Canada
3
Division of Medical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2016, 23(3), 154-163; https://doi.org/10.3747/co.23.3024
Submission received: 8 March 2016 / Revised: 7 April 2016 / Accepted: 11 May 2016 / Published: 1 June 2016

Abstract

Background: Concerns have been raised about the potential influence of political pressures on drug funding decisions. We evaluated the temporal relationship between cancer drug funding and provincial elections in 9 Canadian provinces. Methods: New indications for cancer drugs between January 2003 and December 2012 were identified, and the dates of official provincial funding dates and election dates between 1 January 2003 and 31 December 2014 were retrieved. The probability of drug funding announcements in the 60-day period preceding a provincial election was evaluated using binomial probability distribution analysis. Results: Data from 9 provinces (all Canadian provinces except Quebec) were available. During the period of interest, 69 new indications for 39 individual drugs were identified. Variation in the availability of funding dates was identified. At the time of data collection, 2 provinces did not have data available for all 69 indications. For the 9 provinces, the number of funded indications during the 60-day period preceding an election ranged from 0 to 3; however, no differences in the proportion of indications funded pre-election were identified. Additional analyses also failed to demonstrate any significant associations with the 90-day period before an election, or the 60- and 90-day periods after an election. Conclusions: We observed no clear temporal relationship between provincial election dates and funding decisions in this recent Canadian sample of new indications for cancer drugs.
Keywords: cancer drugs; drug funding; elections; politics cancer drugs; drug funding; elections; politics

Share and Cite

MDPI and ACS Style

Srikanthan, A.; Gill, S.S.; Chan, K.K.W. Provincial Elections and Timing of Cancer Drug Funding. Curr. Oncol. 2016, 23, 154-163. https://doi.org/10.3747/co.23.3024

AMA Style

Srikanthan A, Gill SS, Chan KKW. Provincial Elections and Timing of Cancer Drug Funding. Current Oncology. 2016; 23(3):154-163. https://doi.org/10.3747/co.23.3024

Chicago/Turabian Style

Srikanthan, A., S.S. Gill, and K.K.W. Chan. 2016. "Provincial Elections and Timing of Cancer Drug Funding" Current Oncology 23, no. 3: 154-163. https://doi.org/10.3747/co.23.3024

Article Metrics

Back to TopTop